Delivery Order SPE2DB22D3004-SPE2DB24FPU38
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,120.20, is a delivery order for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $8,998.22 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, with a period of performance through August 16, 2024. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by the DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,161.08 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,741.62 firm-fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,030.50, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of March 20, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite...
- This federal contract award is a $39,448.54 firm-fixed price delivery order for Ozempic 0.25-0.5 mg/dose pens, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award has an ultimate completion date of May 20, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,468.07 firm fixed-price delivery order is for Ozempic 0.25-0.5 mg/dose pens, with a completion date of January 22, 2025. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,831.88 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award from the Defense Logistics Agency (DLA) is a $21,736.29 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp for the provision of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of April 19, 2023 and was awarded on April 18, 2023. This award does not appear to have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $9,182.87 fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPU38Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,126.51 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has no set-aside designation. The IDC was awarded solely to Amerisourcebergen Drug Corp as a single award contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 3/27/24 |